JP Morgan Maintains Overweight on Inspire Medical Systems, Raises Price Target to $340
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Robbie Marcus maintains an Overweight rating on Inspire Medical Systems (NYSE:INSP) and raises the price target from $300 to $340.
August 04, 2023 | 11:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on Inspire Medical Systems and raises the price target from $300 to $340, indicating a positive outlook for the company.
The raised price target by JP Morgan indicates a positive outlook for Inspire Medical Systems. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100